Prospects and advancements in C-reactive protein detection

Area of Science:

• Biochemistry
• Biomedical Engineering
• Clinical Diagnostics

Background:

• C-reactive protein (CRP) is a crucial early biomarker for systemic inflammation.
• Its significance persists despite the identification of later-acting organ-specific markers.
• Early detection of inflammation is vital for timely clinical intervention.

Purpose of the Study:

• To summarize the historical development of C-reactive protein (CRP) detection methods.
• To highlight advancements in CRP detection, focusing on biosensor technology.
• To facilitate the clinical application of novel CRP detection methods for early disease diagnosis.

Main Methods:

• Review of classical antigen-antibody based detection methods (precipitation, agglutination).
• Evolution to CRP-based enzymatic assays and surface plasma spectroscopy.
• Development and integration of nanomaterial-based electrochemical biosensors.

Main Results:

• Nanomaterial-based electrochemical biosensors offer high sensitivity and portability.
• Technologies include silicon nanowires, transistors, ZnS nanoparticles, and aptamers.
• These biosensors represent a significant advancement over earlier detection techniques.

Conclusions:

• Biosensor technology represents the forefront of CRP detection.
• Advancements in CRP detection are critical for early diagnosis of inflammatory conditions.
• Translating biosensor developments into clinical practice can improve patient outcomes.